Caricamento...
Development of an automated platform for the optimal production of glycoconjugate vaccines expressed in Escherichia coli
Protein Glycan Coupling Technology (PGCT) uses purposely modified bacterial cells to produce recombinant glycoconjugate vaccines. This vaccine platform holds great potential in this context, namely due to its modular nature, the simplified production process in comparison to traditional chemical con...
Salvato in:
| Pubblicato in: | Microb Cell Fact |
|---|---|
| Autori principali: | , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
BioMed Central
2021
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8142613/ https://ncbi.nlm.nih.gov/pubmed/34030723 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12934-021-01588-1 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|